Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

3.11
Delayed Data
As of 2:25pm ET
 -0.07 / -2.20%
Today’s Change
2.68
Today|||52-Week Range
7.15
-19.85%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close3.18
Today’s open3.13
Day’s range2.95 - 3.17
Volume56,252
Average volume (3 months)36,482
Market cap$32.3M
Dividend yield--
Data as of 2:25pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+92.31%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...+0.05+2.75%
CBLICleveland Biolabs In...+0.21+6.40%
VKTXViking Therapeutics ...+0.05+3.60%
SLNOSoleno Therapeutics ...-0.01-1.72%
Data as of 2:42pm ET, 09/25/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
Chairman, President &
Chief Executive Officer
Glynn Wilson
Chief Financial Officer, Secretary &
Treasurer
Michael J. Loiacono
Corporate headquarters
Jacksonville, Florida

Forecasts